UK: PAI and Carlyle take Theramex from CVC

France-based private equity firm, PAI Partners, and Nasdaq listed global investment company, Carlyle, have agreed to acquire Theramex, the leading global specialty pharmaceuticals company focused on women’s health, from CVC Capital Partners VI. Theramex provides patient-focused solutions across contraception, fertility, menopause, and osteoporosis. Under CVC Funds’ ownership, Theramex has invested in digital capabilities and executed…

You must be a HMI Subscriber to view this content.

Subscribe Now »